1. Stocks
  2. Novartis AG - ADR
  3. Swot
swot-logo

Novartis AG - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Novartis AG - ADR has 17 Strengths, 6 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout First Resistance ( LTP > R1)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Stocks with strong dividend yields in FY25 and healthy growth over 5 years

Strong Momentum: Price above short, medium and long term moving averages

Mid-range Performer (DVM)

Relative Outperformance versus Industry over the Quarter (3 Months)

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Near 52 Week High

Increasing Revenue every Quarter for the past 4 Quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Increasing profits every quarter for the past 2 quarters

Positive Breakout (LTP > R1)

Top Gainers

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

MACD Crossover Below Signal Line

PE higher than Industry PE

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

MACD crossed below signal line previous end of day

Declining Net Cash Flow : Companies not able to generate net cash

Companies Increasing Debt as per Annual Report

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Institutions decreased their shareholding last quarter

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks